CluePoints Newsroom

Serving up the latest news and information about CluePoints

View all of our News Articles
August 5, 2020 in Blog

Webinar: The Future of Clinical Trial Monitoring

In the wake of COVID-19, adoption of decentralized clinical research is taking off as sponsors explore ways to maintain continuity for existing studies while looking…
Read More
August 4, 2020 in Blog, News

Over 300 Clinical Studies Benefit from CluePoints’ COVID-19 Risk Management Support

Addressing COVID-19 Specific Regulatory Guidance and Ensuring Early Risk Detection   King of Prussia, PA  – August 4th, 2020: CluePoints, the premier provider of Risk-Based…
Read More
July 20, 2020 in Blog

New Paper: From RBM to RBQM – The Future of Risk-Based Trial Management

A review of FDA marketing submissions between 2000 and 2012 revealed roughly one-third (32%) of all first-cycle review failures (16% of submissions overall) were driven…
Read More
July 13, 2020 in Blog, News

CluePoints & DIA Webinar: How is the Industry Coping with the Move to Remote Monitoring?

On July 28, CluePoints is teaming up with DIA for a webinar to explore how the clinical research industry is coping with the move to…
Read More
July 1, 2020 in Blog

RBQM Doesn’t have to be Complicated, Risky or Expensive: Q&A

On Wednesday, June 24, 2020, CluePoints delivered a webinar to demonstrate how using a combination of powerful analytics and comprehensive data visualization can be employed…
Read More
June 25, 2020 in Blog, News

CluePoints Launches Powerful Business Intelligence Platform

Personalizing the Power of Statistical Analysis and Data Visualization King of Prussia, PA  – June 26, 2020: CluePoints, the premier provider of Risk-Based Study Execution…
Read More
June 2, 2020 in Blog

New Webinar: Risk-Based Quality Management Doesn’t have to be Complicated, Risky or Expensive!

Register Now for our June 24, 2020 Webinar:Risk Detection and Data Visualization Techniques that Actually Deliver on the Promise. Managing and mitigating risk, particularly in…
Read More
May 7, 2020 in Blog, COVID-19, News

CluePoints Covid-19 Support Benefits Over 200 Clinical Studies Directly Affected by the Pandemic

RISK MANAGEMENT SOLUTION ADDRESSES FDA, EMA, PMDA & MHRA CORONAVIRUS ADVICE King of Prussia, PA  – May 07, 2020: CluePoints, the premier provider of Risk-Based…
Read More
April 30, 2020 in Blog, COVID-19, COVID-19 Webinar

Beyond COVID-19: The New Normal in Risk-Based Monitoring (RBM) and Quality Management (RBQM)

Join our next webinar to learn first-hand how the CluePoints and Parexel partnership is driving best-in-class Risk-Based Quality Management Strategies to support clinical development. This…
Read More
April 14, 2020 in Blog, News

EPS Corporation Signs Groundbreaking Agreement To Drive Increased Quality And Safety Using CluePoints RBQM Solution

King of Prussia, PA  – April 14, 2020: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials,…
Read More


Find out where we’re headed next.

Featured Whitepaper

ICH E6 (R2)

Created in conjunction with our peers at TUFTS Center for the Study of Drug Development, this paper provides insights on how companies are responding to ICH E6 (R2) and information on the key themes on adoption.

Learn More

Featured Webinar

ICH E6 (R2)

This recorded webinar covers all of the frequently asked Questions about ICH E6 (R2), Risk-Based Study Execution (RBx) and what’s required from a people, process & technology standpoint.

Learn More

We're Kind of a Big Deal.


Platform Users


Studies De-Risked


Issues Detected